94 related articles for article (PubMed ID: 7977760)
1. Transgenic models for study of pulmonary development and disease.
Glasser SW; Korfhagen TR; Wert SE; Whitsett JA
Am J Physiol; 1994 Nov; 267(5 Pt 1):L489-97. PubMed ID: 7977760
[TBL] [Abstract][Full Text] [Related]
2. Isolation of epithelial, endothelial, and immune cells from lungs of transgenic mice with oncogene-induced lung adenocarcinomas.
Bantikassegn A; Song X; Politi K
Am J Respir Cell Mol Biol; 2015 Apr; 52(4):409-17. PubMed ID: 25347711
[TBL] [Abstract][Full Text] [Related]
3. Genetically engineered mouse models for lung cancer.
Kwak I; Tsai SY; DeMayo FJ
Annu Rev Physiol; 2004; 66():647-63. PubMed ID: 14977417
[TBL] [Abstract][Full Text] [Related]
4. Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice.
Wikenheiser KA; Clark JC; Linnoila RI; Stahlman MT; Whitsett JA
Cancer Res; 1992 Oct; 52(19):5342-52. PubMed ID: 1394139
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice.
Dang TP; Eichenberger S; Gonzalez A; Olson S; Carbone DP
Oncogene; 2003 Apr; 22(13):1988-97. PubMed ID: 12673204
[TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of a small cell lung cancer transcription factor, INSM1 impairs alveologenesis in lung development.
Chen C; Breslin MB; Lan MS
BMC Pulm Med; 2016 Apr; 16():49. PubMed ID: 27072116
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic mice.
Ohashi K; Takigawa N; Osawa M; Ichihara E; Takeda H; Kubo T; Hirano S; Yoshino T; Takata M; Tanimoto M; Kiura K
Cancer Res; 2009 Sep; 69(17):7088-95. PubMed ID: 19690148
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mouse models for lung cancer.
Zhao B; Magdaleno S; Chua S; Wang YL; Burcin M; Elberg D; Finegold M; Tsai S; DeMayo FJ
Exp Lung Res; 2000 Dec; 26(8):567-79. PubMed ID: 11195456
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
Ritland SR; Rowse GJ; Chang Y; Gendler SJ
Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas.
Lebel M; Webster M; Muller WJ; Royal A; Gauthier J; Mes-Masson AM
Cell Growth Differ; 1995 Dec; 6(12):1591-600. PubMed ID: 9019164
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.
Bonner AE; Lemon WJ; Devereux TR; Lubet RA; You M
Oncogene; 2004 Feb; 23(5):1166-76. PubMed ID: 14647414
[TBL] [Abstract][Full Text] [Related]
12. Development of pulmonary bronchiolo-alveolar adenocarcinomas in transgenic mice overexpressing murine c-myc and epidermal growth factor in alveolar type II pneumocytes.
Ehrhardt A; Bartels T; Geick A; Klocke R; Paul D; Halter R
Br J Cancer; 2001 Mar; 84(6):813-8. PubMed ID: 11259097
[TBL] [Abstract][Full Text] [Related]
13. Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic mice.
Duan W; Ding H; Subler MA; Zhu WG; Zhang H; Stoner GD; Windle JJ; Otterson GA; Villalona-Calero MA
Oncogene; 2002 Nov; 21(51):7831-8. PubMed ID: 12420220
[TBL] [Abstract][Full Text] [Related]
14. Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene.
Zhou L; Dey CR; Wert SE; Whitsett JA
Dev Biol; 1996 May; 175(2):227-38. PubMed ID: 8626028
[TBL] [Abstract][Full Text] [Related]
15. Tumors in mice transgenic for the envelope protein of Jaagsiekte sheep retrovirus.
Dakessian RM; Inoshima Y; Fan H
Virus Genes; 2007 Aug; 35(1):73-80. PubMed ID: 17043760
[TBL] [Abstract][Full Text] [Related]
16. Investigating stem cells in the lung.
Magdaleno SM; Barrish J; Finegold MJ; DeMayo FJ
Adv Pediatr; 1998; 45():363-96. PubMed ID: 9742309
[TBL] [Abstract][Full Text] [Related]
17. Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16.
Tung YT; Huang PW; Chou YC; Lai CW; Wang HP; Ho HC; Yen CC; Tu CY; Tsai TC; Yeh DC; Wang JL; Chong KY; Chen CM
Oncotarget; 2015 Apr; 6(12):10222-38. PubMed ID: 25912305
[TBL] [Abstract][Full Text] [Related]
18. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo.
Zeng X; Wert SE; Federici R; Peters KG; Whitsett JA
Dev Dyn; 1998 Mar; 211(3):215-27. PubMed ID: 9520109
[TBL] [Abstract][Full Text] [Related]
19. Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer.
Tchou-Wong KM; Jiang Y; Yee H; LaRosa J; Lee TC; Pellicer A; Jagirdar J; Gordon T; Goldberg JD; Rom WN
Am J Respir Cell Mol Biol; 2002 Aug; 27(2):186-93. PubMed ID: 12151310
[TBL] [Abstract][Full Text] [Related]
20. Tumor progression and cellular differentiation of pulmonary adenocarcinomas in SV40 large T antigen transgenic mice.
Wikenheiser KA; Whitsett JA
Am J Respir Cell Mol Biol; 1997 Jun; 16(6):713-23. PubMed ID: 9191473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
